What's breaking now, across thousands of outlets.
The FDA approves Revolution Medicines’ Rasonque for metastatic pancreatic cancer after a trial showed the drug doubled survival for patients.
We haven't written up this one. Arutz Sheva - Israel National News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
(MedPage Today) -- When the temperature heats up, so do emergency rooms, according to a massive study of Chicago hospital and urgent care records, which found increased accidental gunshot wounds…
Researchers investigating the role of progranulin in cancer progression have previously identified the signaling receptor EphA2 as critical in tumor establishment and a potential target to enhance the…
When a cell gets ready to divide, it shuts down its gene-reading machinery almost entirely. For decades, the mechanism behind that shutdown was only partially understood.
The specific signs that separate genuine seasonal allergies from a cold, a sinus infection, or something that needs actual treatment
